JPMorgan Chase & Co. Issues Positive Forecast for Hamilton Lane (NASDAQ:HLNE) Stock Price

Hamilton Lane (NASDAQ:HLNEGet Free Report) had its target price raised by equities research analysts at JPMorgan Chase & Co. from $134.00 to $175.00 in a research report issued on Thursday,Benzinga reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price suggests a potential downside of 8.23% from the company’s previous close.

Several other research firms also recently commented on HLNE. UBS Group raised their price target on shares of Hamilton Lane from $150.00 to $185.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 22nd. Wells Fargo & Company raised their price target on shares of Hamilton Lane from $156.00 to $170.00 and gave the stock an “equal weight” rating in a research report on Wednesday, October 9th. Keefe, Bruyette & Woods lifted their target price on shares of Hamilton Lane from $181.00 to $215.00 and gave the company a “market perform” rating in a report on Thursday. The Goldman Sachs Group boosted their price target on shares of Hamilton Lane from $139.00 to $147.00 and gave the stock a “neutral” rating in a report on Thursday, October 3rd. Finally, Morgan Stanley boosted their price target on shares of Hamilton Lane from $140.00 to $182.00 and gave the stock an “equal weight” rating in a report on Thursday, October 10th. Seven research analysts have rated the stock with a hold rating, According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $179.00.

Read Our Latest Research Report on HLNE

Hamilton Lane Trading Down 1.0 %

Shares of HLNE traded down $1.93 during midday trading on Thursday, hitting $190.70. The stock had a trading volume of 174,784 shares, compared to its average volume of 315,617. The firm has a market cap of $10.34 billion, a PE ratio of 43.60 and a beta of 1.18. Hamilton Lane has a 1 year low of $86.20 and a 1 year high of $196.60. The stock’s 50 day moving average is $167.61 and its 200 day moving average is $141.67. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.72 and a quick ratio of 2.72.

Hamilton Lane (NASDAQ:HLNEGet Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $1.07 EPS for the quarter, topping the consensus estimate of $1.06 by $0.01. The company had revenue of $150.00 million for the quarter, compared to the consensus estimate of $151.55 million. Hamilton Lane had a net margin of 26.99% and a return on equity of 34.36%. The firm’s revenue was up 18.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.89 EPS. As a group, analysts forecast that Hamilton Lane will post 4.9 EPS for the current fiscal year.

Institutional Trading of Hamilton Lane

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in Hamilton Lane by 8.3% in the 1st quarter. Vanguard Group Inc. now owns 3,678,617 shares of the company’s stock valued at $414,801,000 after purchasing an additional 283,190 shares during the last quarter. American Century Companies Inc. raised its stake in Hamilton Lane by 30.3% during the 2nd quarter. American Century Companies Inc. now owns 580,768 shares of the company’s stock worth $71,772,000 after acquiring an additional 135,040 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in Hamilton Lane during the 1st quarter worth $11,445,000. Principal Financial Group Inc. increased its stake in Hamilton Lane by 20.2% in the third quarter. Principal Financial Group Inc. now owns 583,721 shares of the company’s stock valued at $98,297,000 after purchasing an additional 97,924 shares during the period. Finally, Capital World Investors acquired a new position in Hamilton Lane in the first quarter valued at $9,724,000. Institutional investors and hedge funds own 97.40% of the company’s stock.

About Hamilton Lane

(Get Free Report)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

See Also

Analyst Recommendations for Hamilton Lane (NASDAQ:HLNE)

Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.